Back to results

Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Primary Purpose

Transient Ischemic Attack, Stroke, Aspirin

Status

Withdrawn

Phase

Phase 1

Locations

United States

Study Type

Interventional

Intervention

aspirin versus clopidogrel

About this trial

This is an interventional prevention trial for Transient Ischemic Attack focused on measuring Transient ischemic attack, Stroke, Aspirin, Clopidogrel

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 18 and older. Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent. Women of child-bearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period. Exclusion Criteria: Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents. Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis. Allergy to aspirin or clopidogrel.

Sites / Locations

UCSD Hillcrest
UCSD

Outcomes

Primary Outcome Measures

mRS at three months.

Secondary Outcome Measures

Incidence of stroke at three months, bleeding events.

Full Information

NCT ID

NCT00363753

First Posted

August 10, 2006

Last Updated

July 31, 2019

Sponsor

University of California, San Diego

1. Study Identification

Unique Protocol Identification Number

NCT00363753

Brief Title

Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Official Title

Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

Study Type

Interventional

2. Study Status

Record Verification Date

July 2019

Overall Recruitment Status

Withdrawn

Study Start Date

August 2006 (undefined)

Primary Completion Date

undefined (undefined)

Study Completion Date

March 2007 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor

University of California, San Diego

4. Oversight

5. Study Description

Brief Summary

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

Detailed Description

Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Transient Ischemic Attack, Stroke, Aspirin, Clopidogrel

Keywords

Transient ischemic attack, Stroke, Aspirin, Clopidogrel

7. Study Design

Primary Purpose

Prevention

Study Phase

Phase 1

Interventional Study Model

Parallel Assignment

Masking

None (Open Label)

Allocation

Randomized

Enrollment

0 (Actual)

8. Arms, Groups, and Interventions

Intervention Type

Drug

Intervention Name(s)

aspirin versus clopidogrel

Primary Outcome Measure Information:

Title

mRS at three months.

Secondary Outcome Measure Information:

Title

Incidence of stroke at three months, bleeding events.

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Accepts Healthy Volunteers

Eligibility Criteria

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Matt B Jensen, MD

Organizational Affiliation

UCSD Stroke Center

Official's Role

Principal Investigator

Facility Information:

Facility Name

UCSD Hillcrest

City

San Diego

State/Province

California

ZIP/Postal Code

92103

Country

United States

Facility Name

UCSD

City

San Diego

State/Province

California

ZIP/Postal Code

92103

Country

United States

12. IPD Sharing Statement

Learn more about this trial

Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack

We'll reach out to this number within 24 hrs